These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1865422)

  • 61. Cyclosporine A in the treatment of aplastic anemia.
    Mackenzie IL; Manoharan A
    Am J Hematol; 1988 Jul; 28(3):211. PubMed ID: 3407643
    [No Abstract]   [Full Text] [Related]  

  • 62. Cyclosporine A in five children with severe aplastic anemia.
    Neira L; Vermylen C; Ninane J; Doyen C; Cornu G
    Pediatr Hematol Oncol; 1990; 7(1):89-98. PubMed ID: 2397171
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hypoalbuminaemia after prolonged treatment with recombinant granulocyte macrophage colony stimulating factor.
    Kaczmarski RS; Mufti GJ
    BMJ; 1990 Dec; 301(6764):1312-3. PubMed ID: 2271856
    [No Abstract]   [Full Text] [Related]  

  • 64. Growth factors in human cancer.
    Gabrilove J; Mendelsohn J
    Curr Opin Oncol; 1990 Feb; 2(1):163-70. PubMed ID: 1710146
    [No Abstract]   [Full Text] [Related]  

  • 65. Effects of haemopoietic growth factors for aplastic anaemia.
    Foot AB; Potter MN; Mott MG; Oakhill A
    Lancet; 1994 Sep; 344(8924):757. PubMed ID: 7915805
    [No Abstract]   [Full Text] [Related]  

  • 66. Clearance of unremitting psoriasis after treatment with granulocyte-macrophage colony-stimulating factor.
    Raychaudhuri SP; Fiore MM
    J Am Acad Dermatol; 1992 Sep; 27(3):451-2. PubMed ID: 1401283
    [No Abstract]   [Full Text] [Related]  

  • 67. Ulcer osteoma and periosteal reactions to chronic leg ulcers.
    Karasick D; Schweitzer ME; Deely DM
    AJR Am J Roentgenol; 1997 Jan; 168(1):155-7. PubMed ID: 8976939
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Successful treatment of gold-induced aplastic anaemia with granulocyte macrophage colony stimulating factor.
    Chasen MR; Sarembock B; Meyers OL
    Br J Rheumatol; 1992 Jun; 31(6):428-9. PubMed ID: 1596710
    [No Abstract]   [Full Text] [Related]  

  • 69. Best cases from the AFIP: Adamantinoma of the tibia and fibula with cytogenetic analysis.
    Camp MD; Tompkins RK; Spanier SS; Bridge JA; Bush CH
    Radiographics; 2008; 28(4):1215-20. PubMed ID: 18635638
    [No Abstract]   [Full Text] [Related]  

  • 70. Cyclosporine for pure red cell aplasia.
    Debusscher L; Paridaens R; Stryckmans P; Delwiche F
    Blood; 1985 Jan; 65(1):249. PubMed ID: 3965050
    [No Abstract]   [Full Text] [Related]  

  • 71. Cyclosporin treatment for aplastic anemia: a case report demonstrating a second response to second exposure to cyclosporin.
    Bern MM; Roberts MS; Yoburn D
    Am J Hematol; 1987 Mar; 24(3):307-9. PubMed ID: 3826057
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cyclosporin associated remission in severe aplastic anaemia.
    Stafford B; Frost T
    Aust N Z J Med; 1991 Apr; 21(2):292-4. PubMed ID: 1872763
    [No Abstract]   [Full Text] [Related]  

  • 73. Images in clinical medicine. A cobwebbing trabecular pattern.
    Young TH; Lee HS
    N Engl J Med; 2007 Nov; 357(22):e24. PubMed ID: 18046023
    [No Abstract]   [Full Text] [Related]  

  • 74. The value of roentgenography in differentiating aplastic anemia from leukemia masquerading as aplastic anemia.
    Shackelford GD; Bloomberg G; McAlister WH
    Am J Roentgenol Radium Ther Nucl Med; 1972 Nov; 116(3):651-4. PubMed ID: 4509038
    [No Abstract]   [Full Text] [Related]  

  • 75. Microstructural analysis of severe bone lesions in seven thalassemic patients treated with deferoxamine.
    de Sanctis V; Savarino L; Stea S; Cervellati M; Ciapetti G; Tassinari L; Pizzoferrato A
    Calcif Tissue Int; 2000 Aug; 67(2):128-33. PubMed ID: 10920217
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term improvement of anaemia in a patient with aplastic anaemia by short-term administration of pegylated recombinant human megakaryocyte growth and development factor.
    Matsuda A; Misumi M; Ishikawa M; Yagasaki F; Jinnai I; Bessho M; Mizoguchi H
    Br J Haematol; 2004 Jun; 125(6):818-9. PubMed ID: 15180875
    [No Abstract]   [Full Text] [Related]  

  • 77. Cyclosporin for refractory aplastic anemia.
    Dundar S; Demirkazik A
    Acta Haematol; 1990; 83(2):112. PubMed ID: 2106196
    [No Abstract]   [Full Text] [Related]  

  • 78. Unusual pattern of marrow distribution following treatment of aplastic anemia.
    Fawcett HD; Sayle BA; Nusynowitz ML; Gardner FH
    Clin Nucl Med; 1989 Jun; 14(6):462-3. PubMed ID: 2743700
    [No Abstract]   [Full Text] [Related]  

  • 79. Clinical toxicity of cytokines used as haemopoietic growth factors.
    Vial T; Descotes J
    Drug Saf; 1995 Dec; 13(6):371-406. PubMed ID: 8652081
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bone remodelling after growth factor and cyclosporine A therapy for aplastic anemia.
    Derfus BA; Csuka ME; Carrera GF; Hanson GA; Smith RE
    J Rheumatol; 1991 May; 18(5):738-42. PubMed ID: 1865422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.